[Oral disease-modifying agents in relapsing-remitting multiple sclerosis]. Iljicsov A, Pal Z, Simo M Neuropsychopharmacol Hung. 2015 Dec; 17(4):197-205. PMID: 26727724. Abstract CommentRecommendBookmarkWatch